Rankings
▼
Calendar
LNTH FY 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
FY 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$339M
-2.3% YoY
Gross Profit
$139M
40.9% margin
Operating Income
-$4M
-1.2% margin
Net Income
-$13M
-4.0% margin
EPS (Diluted)
$-0.25
Cash Flow
Operating Cash Flow
$16M
Free Cash Flow
$4M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$870M
Total Liabilities
$356M
Stockholders' Equity
$514M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$339M
$347M
-2.3%
Gross Profit
$139M
$175M
-20.6%
Operating Income
-$4M
$52M
-108.1%
Net Income
-$13M
$32M
-142.5%
← Q4 2019
All Quarters
Q1 2020 →